The association between DBT (Dihydrolipoamide Branched Chain Transacylase E2) and Maple Syrup Urine Disease, Type Ii is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic and likely-pathogenic variants, and causative variation.
Sources4
Clinical variants48
Symptoms11
Compounds0
Trials0
Publications10
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.